Journals / Acıbadem Üniversitesi Sağlık Bilimleri Dergisi / 2019 / Sayı: 2

Evaluation of The Relationship Between Waist Height Ratio and Other Anthropometric Measures In The Risk of Chronic Diseases

Bel/Boy Oranı ve Diğer Antropometrik Ölçümlerin Kronik Hastalık Riski ile İlişkisinin Değerlendirilmesi

Pages
241–246
Publication Date
2019-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a positive and significant correlation between BMI, waist circumference, waist to height ratio, waist to hip ratio and fasting blood glucose, HbA1c, LDL cholesterol and TG p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this work was to determine the relationship between the anthropometric measurements used in the definition of obesity and biochemical markers which is related to risk of chronic diseases such as type 2 DM and cardiovascular disease.Materials and Methods: This study was carried out on 180 participants aged 18-85 years 146 women, 34 men and applied between 02 January 2014 and 31 December 2014 at Başkent Ankara Hospital Ümitköy Diet Polyclinic.
📊
Key Findings & Data:The participants biochemical and anthropometric data were evaluated.Results: The mean BMI of study group was 28.8±5.25 kg/m2 and waist to height ratio of study group was 0.53±0.10. 39.7% of the women and 50% of the men were in the risk group for waist circumference values.
💡
Conclusion & Impact:There was a positive and significant correlation between BMI, waist circumference, waist to height ratio, waist to hip ratio and fasting blood glucose, HbA1c, LDL cholesterol and TG p
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Waist to height ratio · obesity · anthropometry

Abstract

Objective: The aim of this work was to determine the relationship between the anthropometric measurements used in the definition of obesity and biochemical markers which is related to risk of chronic diseases such as type 2 DM and cardiovascular disease.Materials and Methods: This study was carried out on 180 participants aged 18-85 years 146 women, 34 men and applied between 02 January 2014 and 31 December 2014 at Başkent Ankara Hospital Ümitköy Diet Polyclinic. The participants biochemical and anthropometric data were evaluated.Results: The mean BMI of study group was 28.8±5.25 kg/m2 and waist to height ratio of study group was 0.53±0.10. 39.7% of the women and 50% of the men were in the risk group for waist circumference values. The frequency of waist to hip ratio in the risk group was 85.3% in women, whereas this frequency was 67.6% in men. There was a positive and significant correlation between BMI, waist circumference, waist to height ratio, waist to hip ratio and fasting blood glucose, HbA1c, LDL cholesterol and TG p

Özet

Amaç: Kardiyovasküler hastalıklar ve Tip 2 DM gibi kronik hastalıkların riskine ilişkin biyokimyasal belirteçlerle, obezite tanısında kullanılan antropometrik ölçümler arasındaki ilişkinin belirlenmesini amaçlamaktadır.Gereç ve Yöntem: Çalışmada Başkent Ankara Hastanesi Ümitköy Diyet Polikliniğine 02 Ocak 2014- 31 Aralık 2014 tarihleri arasında başvuran ve yaşları 18-85 arasında değişen 180 kişinin 146 kadın, 34 erkek biyokimyasal ve antropometrik verileri değerlendirilmiştir.Bulgular: Araştırmaya katılan bireylerin BKİ ortalaması 28.8±5.25 kg/m2, bel/boy ortalaması 0.53±0.10 olarak bulunmuştur. Kadınların %39.7’sinin, erkeklerin %50’sinin bel çevresi değerleri riskli gruptadır. B/K oranları riskli grupta olan kadınların sıklığı %85.3 iken erkeklerde bu sıklık %67.6’dır. BKİ, bel çevresi ve bel/boy oranı ve B/K oranı ile, AKG, HbA1c, LDL-K ve TG ile pozitif yönde, HDL-K ile negatif yönde ve istatistiksel açıdan anlamlı bir ilişki saptanmıştır p

🔖

Cite This Article

YEŞİL, E., ÖZDEMİR, M., ARITICI, G., AKSOYDAN, E. (2019). Evaluation of The Relationship Between Waist Height Ratio and Other Anthropometric Measures In The Risk of Chronic Diseases. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 2, 241–246. https://ajindex.com/articles/162876

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Xu Z., Qi X., Dahl A. K., Xu W. Waist‐to‐height ratio is the best indicator for undiagnosed Type 2 diabetes. Diabetic Med 2013;30:e201-7. [CrossRef] Ashwell MP, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012;13: 275–86. [CrossRef] Liu Y, Tong G, Tong W, Lu L, Qin X. Can body mass index, waist circumference waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects? BMC Public Health 2011; 11:35. [CrossRef] Sabah KMDN, Chowdhury AW, Khan HILR, Hasan H, Haque S, Ali S, Kawser S, Alam N, Amin G, Mahabub SME. Body mass index and waist/height ratio for prediction of severity of coronary artery disease. BMC Research Notes 2014; 7:246. [CrossRef] Kodama S, Horikawa C, Fujihara K, Heianza Y, Hirasawa R, Yachi Y, Sugawara A, Tanaka S, Shimano H, Iida KT, Saito K, Sone H. Comparisons of the Strength of Associations With Future Type 2 Diabetes Risk Among Anthropometric Obesity Indicators, Including Waist-to-Height Ratio: A Meta-Analysis. Am J Epidemiol 2012;176:959–69 [CrossRef] World Health Organization (2000a). Obesity: Preventing and Managing the Global Epidemic. WHO Technical report series No. 894. WHO: Geneva. https://www.who.int/nutrition/publications/ obesity/WHO_TRS_894/en/ (Erişim tarihi: 28.03.2019) Tanı ve Tedavi Kılavuzu, 2018 http://temd.org.tr/admin/uploads/ tbl_kilavuz/20180516162841-2018-05-16tbl_kilavuz162840.pdf. Erişim Tarihi:16.04.2019
  2. Ashwell M, Browning LM. The Increasing Importance of Waist-to- Height Ratio to Assess Cardiometabolic Risk: A Plea for Consistent Terminology. The Open Obesity Journal, 2011;3:70-7. [CrossRef] World Health Organization (2008, DECEMBER 8–11). Waist Circumference and Waist-Hip Ratio. Report of a WHO Expert Consultation. Geneva. https://apps.who.int/iris/bitstream/ handle/10665/44583/9789241501491_eng.pdf?ua=1 (Erişim tarihi: 28.03.2019)
  3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ. Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52. [CrossRef] Kuk JL, Ardern CI. Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality? Diabetes Care 2009; 32: 2297-9. [CrossRef] Rajput R, Rajput M, Bairwa